Table 2

Differential regulation of cellular pathways in response to IR between apoptosis-sensitive and -resistant ALL tumors by GSEA analysis

Pathway nameNo. genes in the pathwayNOM PFDR q
PDGF 20 .005 
PTEN 16 .007 
Insulin 18 .007 
EGF 20 .006 
B-cell receptor complexes 16 .002 .02 
IGF1 17 .027 
Oxidative phosphorylation 29 .01 .052 
CREB 19 .002 .064 
mRNA processing 18 .092 
Inositol phosphate metabolism 15 .008 .095 
S1P signaling 16 .004 .088 
Insulin receptor pathway in cardiac myocytes 43 .008 .134 
mRNA splicing 20 .017 .162 
TPO pathway 17 .031 .215 
Insulin signaling 19 .014 .201 
IL6 pathway 18 .051 .238 
G13 signaling pathway 17 .027 .226 
IL2 17 .017 .243 
TRKA receptor 15 .036 .247 
Pathway nameNo. genes in the pathwayNOM PFDR q
PDGF 20 .005 
PTEN 16 .007 
Insulin 18 .007 
EGF 20 .006 
B-cell receptor complexes 16 .002 .02 
IGF1 17 .027 
Oxidative phosphorylation 29 .01 .052 
CREB 19 .002 .064 
mRNA processing 18 .092 
Inositol phosphate metabolism 15 .008 .095 
S1P signaling 16 .004 .088 
Insulin receptor pathway in cardiac myocytes 43 .008 .134 
mRNA splicing 20 .017 .162 
TPO pathway 17 .031 .215 
Insulin signaling 19 .014 .201 
IL6 pathway 18 .051 .238 
G13 signaling pathway 17 .027 .226 
IL2 17 .017 .243 
TRKA receptor 15 .036 .247 

NOM P indicates nominal probability.